Chemical Compound

Cyclopenta(c)(1)benzopyran-8-ol, 1,2,3,3a,4,9b-hexahydro-4-(4-hydroxyphenyl)-, (3aS,4R,9bR)-

CAS Registry Number 533884-09-2
Cyclopenta(c)(1)benzopyran-8-ol, 1,2,3,3a,4,9b-hexahydro-4-(4-hydroxyphenyl)-, (3aS,4R,9bR)- 结构式
Primary record

Cyclopenta(c)(1)benzopyran-8-ol, 1,2,3,3a,4,9b-hexahydro-4-(4-hydroxyphenyl)-, (3aS,4R,9bR)-

库存
4,600 克
纯度
99.0 %
CAS
533884-09-2

化合物标识与属性

CAS
533884-09-2
PubChem CID
10286159
SMILES
C1C[C@H]2[C@@H](C1)C3=C(C=CC(=C3)O)O[C@H]2C4=CC=C(C=C4)O
Canonical SMILES
Oc1ccc([C@@H]2Oc3ccc(O)cc3[C@@H]3CCC[C@@H]32)cc1

名称与同义词

  • Erteberel
  • erteberelum
  • 533884-09-2
  • LY500307
  • racemic mixture
  • SERBA-1
  • Erteberel [USAN]
  • Erteberel (LY500307)
  • Erteberel [USAN:INN]
  • 2i0g
  • 2i0j
  • ERTEBEREL [INN]
  • Erteberel (USAN/INN)
  • RefChem:591094
  • 2ZUL6758TZ
  • UNII-2ZUL6758TZ
  • D0R2SK
  • ERTEBEREL [WHO-DD]
  • DTXSID70201547
  • (3aS,4R,9bR)-4-(4-hydroxyphenyl)-1,2,3,3a,4,9b-hexahydrocyclopenta[c]chromen-8-ol
  • CHEMBL278703
  • LY-500307
  • orb1300884
  • C18H18O3
  • ER beta agonist (BPH), Lilly
  • SCHEMBL14102383
  • BDBM19968
  • DTXCID00124038
  • EX-A157
  • BCPP000173
  • GLXC-15787
  • ABP000948
  • MFCD22495234
  • ZINC12353762
  • Benzopyran derivative., 4b(racemate)
  • AKOS027323752
  • BCP9000889
  • DB07933
  • LY 500307
  • CID10286159
  • NCGC00346557-01
  • NCGC00346557-02
  • AC-36799
  • HY-18295
  • MS-24010
  • LY500307/
  • CS-0007402
  • FT-0773068
  • NS00070542
  • X7545
  • D09899
  • Z-3119
  • A870737
  • BRD-K80608265-001-01-6
  • Q27097167
  • Cyclopenta(c)(1)benzopyran-8-ol, 1,2,3,3a,4,9b-hexahydro-4-(4-hydroxyphenyl)-, (3aS,4R,9bR)-
  • (3aS,4R,9bR)-1,2,3,3a,4,9b-Hexahydro-4-(4-hydroxyphenyl)cyclopenta[c][1]benzopyran-8-ol
  • (3aS,4R,9bR)-4-(4-Hydroxyphenyl)-1,2,3,3a,4,9b-hexahydrocyclopenta(c)(1) benzopyran-8-ol
  • LY 500307,LY-500307, 533884-09-2
  • I0G
  • (3aS,4R,9bR)-1,2,3,3a,4,9b-Hexahydro-4-(4-hydroxyphenyl)cyclopenta(c)(1)benzopyran-8-ol
  • (3aS,4R,9bR)-4-(4-Hydroxyphenyl)-1,2,3,3a,4,9b-hexahydrobenzo[b]cyclopenta[d]pyran-8-ol
  • Lead estrogen receptor beta agonists (benign prostatic hyperplasia),Eli Lilly
  • (2R,6S,7R)-7-(4-hydroxyphenyl)-8-oxatricyclo(7.4.0.02,?)trideca-1(9),10,12-trien-12-ol
  • (2R,6S,7R)-7-(4-hydroxyphenyl)-8-oxatricyclo[7.4.0.0;{2,6}]trideca-1(13),9,11-trien-12-ol
  • (2R,6S,7R)-7-(4-hydroxyphenyl)-8-oxatricyclo[7.4.0.0;{2,6}]trideca-1(9),10,12-trien-12-ol
  • (2R,6S,7R)-7-(4-hydroxyphenyl)-8-oxatricyclo[7.4.0.0^{2,6}]trideca-1(13),9,11-trien-12-ol
  • (2R,6S,7R)-7-(4-hydroxyphenyl)-8-oxatricyclo[7.4.0.0^{2,6}]trideca-1(9),10,12-trien-12-ol
  • (3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA(C)(1)BENZOPYRAN-8-OL